EP. 1: Dr. Ma on Utilizing Zanabrutinib in CLL
Shuo Ma, MD, PhD, discusses the utilization of zanubrutinib in chronic lymphocytic leukemia.
EP. 2: Dr. Heyman on the ALPINE Trial in CLL
Benjamin Heyman, MD, discusses the phase 3 ALPINE trial in chronic lymphocytic leukemia.
EP. 3: Dr. Furman on Current Treatment Options in CLL
Richard R. Furman, MD, discusses current treatment options in chronic lymphocytic leukemia.
EP. 4: New Directions in Chronic Lymphocytic Leukemia
This publication highlights expert perspectives on the current therapeutic landscape in chronic lymphocytic leukemia with emphasis on factors affecting treatment selection including novel regimens, combination therapies, and ongoing clinical trials.
Dr Deek on the Investigation of Immune Cell Infiltration in MIBC
Hypofractionated and Conventionally Fractionated Radiotherapy Generate Similar QOL, Safety in Breast Cancer
Dr Hoppe on the Rationale for the CheckMate 744 Trial in Hodgkin Lymphoma
Dr Chuong on the Patterns of Guided Radiation Therapy in Pancreatic Cancer
2 Clarke Drive Cranbury, NJ 08512